GleamWall
中文EN

LMMY Exousia Bio, Inc.

Services-Educational Services · OTC · SEC CIK 1939937 · Fiscal year ends 05/31

Financial factors as of 2026-02-28 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-100.0%
TTM net income YoY-148.6%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-0.7%
ROA-0.7%
ROIC (approx.)—
Asset turnover0.00x

Leverage & solvency

Liabilities / assets1.2%
Debt / equity0.00x
Current ratio0.00x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-2.36x
Accruals ratio-2.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-05-31FY20242024-05-31
Income statement
Revenue$3,750$11,500
Cost of revenue$7,251$9,667
Gross profit-$3,501$1,833
SG&A expense$28,380$28,076
Pretax income$51,395-$25,807
Income tax$0$0
Net income$51,395-$25,807
EPS (basic)0.000.00
EPS (diluted)0.000.00
Weighted avg. shares (diluted)7.78M7.78M
Balance sheet
Cash & equivalents$0$1,028
Receivables$0$11,500
Current assets$0$12,964
PP&E, net$0$4,952
Intangibles$0$9,537
Total assets$0$27,453
Current liabilities$0$14,169
Total liabilities$0$82,348
Shareholders' equity$0-$54,895
Shares outstanding7.78M7.78M
Cash flow statement
Operating cash flow-$4,528-$12,484
Investing cash flow$0$0
Financing cash flow$3,500$5,657
Depreciation & amortization$3,775$5,033

Free plan shows the latest 2 periods; Pro shows all 3 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.